Cornovus Pharmaceuticals
Farmington
About Cornovus Pharmaceuticals
Cornovus Pharmaceuticals is a developer of a heart attack drug used to treat cardiac hypertrophy and heart failure. The technology increases myocardial cyclic guanosine-monophosphate which may play a role in cardia function and reperfusion enables heart attack victims to delay the onset of heart failure after a heart attack or injury. It was founded in 2011 and is headquartered in Farmington, Connecticut.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $3.1M
- Last round: Series Unknown (Jan 2024)
- Website: cornovus.com
Industries & Categories
Health Care, Health Diagnostics, Medical, Medical Device
Canonical: https://fsome.com/organization/cornovus-pharmaceuticals-72121 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.